SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited scores highest on Earnings (43) and lowest on Price (0). Its PosiPenta is 14.10 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, SymBio Pharmaceuticals Limited is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,058 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| SymBio Pharmaceuticals Limited | 14.10 | 0 | 43 | 2 | 6 | 20 |
| Kohjin Bio Co., Ltd. | 34.55 | 54 | 39 | 9 | 36 | 36 |
| AIAI Group Corporation | 49.19 | 82 | 63 | 15 | 46 | 40 |
| GIMIC Co., Ltd. | 50.57 | 80 | 58 | 12 | 72 | 31 |
| Hi-CRATES CO.,LTD. | 68.48 | 80 | 55 | 65 | 83 | 60 |
| PRISM BioLab Co.,LTD | 23.97 | 13 | 16 | 17 | 53 | 21 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.49 |
| P/B ratio | -6.46 |
EEarnings
| Trailing EPS | ₹-58.51 |
| Forward EPS | ₹23.67 |
NNitro
| Price | 28.45 |
| 52-week high | 138.63 |
| 52-week low | 27.85 |
| Fall from 52-week high | 79.5% |
TTorque
| Return on equity (ROE) | -677.08% |
| Debt-to-equity | 1.56 |
AAnchor
| Beta (price swings) | 0.55 |
| Market cap | ₹228 Cr |
| Insider holding | 9.31% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is SymBio Pharmaceuticals Limited's PosiPenta score?
SymBio Pharmaceuticals Limited's PosiPenta is 14.10 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does SymBio Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, SymBio Pharmaceuticals Limited is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,058 of 1,059 in Japan.
Which PosiPenta pillar is strongest for SymBio Pharmaceuticals Limited?
Earnings (growth), with a score of 43 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for SymBio Pharmaceuticals Limited?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.